Chinese Journal of Stroke ›› 2021, Vol. 16 ›› Issue (10): 1067-1074.DOI: 10.3969/j.issn.1673-5765.2021.10.016
Previous Articles Next Articles
Received:
2021-04-05
Online:
2021-10-20
Published:
2021-10-20
刘颖, 丁晶, 汪昕
通讯作者:
汪昕 wang.xin@zs-hospital.sh.cn
基金资助:
LIU Ying, DING Jing, WANG Xin. Advances in Futile Recanalization of Endovascular Thrombectomy for Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2021, 16(10): 1067-1074.
刘颖, 丁晶, 汪昕. 急性缺血性卒中血管内治疗无效再通的研究进展[J]. 中国卒中杂志, 2021, 16(10): 1067-1074.
[1] 王拥军,李子孝,谷鸿秋,等. 中国卒中报告2019(中 文版)(1)[J]. 中国卒中杂志,2020,15(10):1037- 1043. [2] 王拥军,李子孝,谷鸿秋,等. 中国卒中报告2019(中 文版)(2)[J]. 中国卒中杂志,2020,15(11):1145- 1155. [3] SMITH W S,LEV M H,ENGLISH J D,et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA[J]. Stroke, 2009,40(12):3834-3840. [4] POWERS W J,RABINSTEIN A A,ACKERSON T,et al. 2018 guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2018,49(3):e46-e110[2021-03-16]. https://doi.org/10.1161/str.0000000000000158. [5] ALBERS G W,MARKS M P,KEMP S,et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med, 2018,378(8):708-718. [6] NOGUEIRA R G,JADHAV A P,HAUSSEN D C, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med,2018,378(1):11-21. [7] VAN HORN N,KNIEP H,LEISCHNER H,et al. Predictors of poor clinical outcome despite complete reperfusion in acute ischemic stroke patients[J]. J Neurointerv Surg,2021,13(1):14-18. [8] HUSSEIN H M,GEORGIADIS A L,VAZQUEZ G,et al. Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke:a multicenter study[J]. Am J Neuroradiol,2010,31(3): 454-458. [9] YOO A J,SIMONSEN C Z,PRABHAKARAN S,et al. Refining angiographic biomarkers of revascularization:improving outcome prediction after intra-arterial therapy[J]. Stroke,2013,44(9): 2509-2512. [10] TOMSICK T,BRODERICK J,CARROZELLA J, et al. Revascularization results in the interventional management of stroke II trial[J]. Am J Neuroradiol, 2008,29(3):582-587. [11] HUSSEIN H M,SALEEM M A,QURESHI A I. Rates and predictors of futile recanalization in patients undergoing endovascular treatment in a multicenter clinical trial[J]. Neuroradiology,2018, 60(5):557-563. [12] ZAIDAT O O,YOO A J,KHATRI P,et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke[J]. Stroke,2013,44(9):2650-2663. [13] GOYAL M,MENON B K,VAN ZWAM W H,et al. Endovascular thrombectomy after large-vessel ischaemic stroke:a meta-analysis of individual patient data from five randomised trials[J]. Lancet, 2016,387(10029):1723-1731. [14] CASETTA I,FAINARDI E,SAIA V,et al. Endovascular thrombectomy for acute ischemic stroke beyond 6 hours from onset[J]. Stroke,2020,51 (7):2051-2057. [15] LIU X F,DAI Q L,YE R D,et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion(BEST):an openlabel, randomised controlled trial[J]. Lancet Neurol, 2020,19(2):115-122. [16] DE MEYER S F,DENORME F,LANGHAUSER F,et al. Thromboinflammation in stroke brain damage[J]. Stroke,2016,47(4):1165-1172. [17] DE WAHA S,PATEL M R,GRANGER C B,et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction:an individual patient data pooled analysis from seven randomized trials[J]. Eur Heart J,2017,38(47):3502-3510. [18] WU M Y,YIANG G T,LIAO W T,et al. Current mechanistic concepts in ischemia and reperfusion injury[J]. Cell Physiol Biochem,2018,46(4):1650- 1667. [19] SUN M S,JIN H,SUN X,et al. Free radical damage in ischemia-reperfusion injury:an obstacle in acute ischemic stroke after revascularization therapy[J/ OL]. Oxid Med Cell Longev,2018:3804979[2021- 03-16]. https://doi.org/10.1155/2018/3804979. [20] MCGARRY T,BINIECKA M,VEALE D J,et al. Hypoxia,oxidative stress and inflammation[J/OL]. Free Radic Biol Med,2018,125:15-24[2021-03-16]. https://doi.org/10.1016/j.freeradbiomed.2018.03.042.
[21] DE PASCALI F,HEMANN C,SAMONS K,et |
[1] | WANG Xiaorui, LUO Song, ZOU Liangyu, QU Hongdang, CUI Xue, ZHAO Yujie. Value of Eosinophil-to-Monocyte Ratio in Predicting the Prognosis of Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(9): 1025-1033. |
[2] | ABULANIYAZI Anaguli, WU Xiaoxin, LI Jiaoxing, LI Zhuhao, SHENG Wenli. Research Progress on Factors Related to the Susceptibility Vessel Sign and its Clinical Application in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1077-1085. |
[3] | WU Chunyan, YIN Yashi, WANG Guangzhi, YUE Kuitao. Evaluation and Application of Medical Imaging for Acute Ischemic Stroke at Different Time Windows: A Review [J]. Chinese Journal of Stroke, 2024, 19(9): 1094-1101. |
[4] | YI Luo, JIANG Yingyu, MENG Xia, JIANG Yong, WANG Yongjun, GU Hongqiu. Development and Validation of a Prediction Model of In-Hospital Neurological Deterioration for Patients with Minor Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(5): 524-531. |
[5] | ZHENG Guomin, LIANG Zhigang, ZHANG Zhen. Research Progress of Tirofiban Combined with Mechanical Thrombectomy in the Treatment of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(5): 573-578. |
[6] | HAO Manjun, WANG Liyuan, XIONG Yunyun. Neuroimaging Evaluation of Reperfusion Therapy [J]. Chinese Journal of Stroke, 2024, 19(4): 459-467. |
[7] | YAN Xige, WANG Guoling, ZHANG Bogang, PENG Min, DONG Zhongjun, SHEN Xiaoping, CHEN Xiuxiao, JIA Qian, DONG Huige, CHENG Li. A Rescue Therapy for Vascular Reocclusion after Carotid Artery Stenting for Acute Carotid Artery Occlusion—Femoral-Carotid Artery Bypass [J]. Chinese Journal of Stroke, 2024, 19(3): 331-336. |
[8] | LIU Yafei, WU Tingting, YAN Shixi, JIA Chong, ZHANG Hanfei, ZHANG Zhongbo, WU Yiping. Progress in Imaging Assessment of Infarct Core Volume in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(3): 349-355. |
[9] | YANG Jiajie, ZHANG Liang, HUANG Li’an. Advances in Pharmacogenomics-Based Individualized Antithrombotic Therapy for Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(10): 1111-1117. |
[10] | CHEN Xubin, XIAO Weiting, YUE Xifeng, HE Nengqing, ZENG Xiaohui. Relationship between Serum MicroRNA-874-3p, MicroRNA-181a-5p, Wnt/β-catenin Signaling Pathway and Neurological Function Prognosis in Patients with Acute Ischemic Stroke after Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(10): 1162-1169. |
[11] | YANG Jiaxin, HE Chunyu, LIU Lei, CHEN Wenbo, XIE Yan. Prediction Models of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review [J]. Chinese Journal of Stroke, 2024, 19(1): 76-86. |
[12] | LU Jing, LI Chuanfa, ZHANG Daqi, CHEN Rong, LI Qifu. Research Progress of Hemorrhagic Transformation after Endovascular Treatment in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(9): 1065-1072. |
[13] | ZHOU Yumeng, CHEN Lixia. Progress on Blood Pressure Management in Patients with Acute Ischemic Stroke Undergoing Mechanical Thrombectomy [J]. Chinese Journal of Stroke, 2023, 18(9): 1073-1078. |
[14] | FAN Ping, YUE Kuitao, LI Aiyuan, ZHAO Zhe, XIE Hai, WU Chunyan ( Contributed equally). . Review of the Application of Radiomics in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(8): 952-957. |
[15] | HAO Manjun, CAO Zhixin, LI Guangshuo, XIONG Yunyun. Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(12): 1357-1364. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||